• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/08/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer reported that they received erroneous results for one patient sample tested for igg antibodies to rubella virus (rubigg).The sample resulted as >2500 iu/ml on an e411 analyzer.The sample was diluted 1:20 and repeated on the e411 analyzer, resulting as 3541 iu/ml (positive).The positive result was reported to the patient and the doctor advised the patient to return after 2 weeks for a re-test.A second sample from the patient was tested on the e411 analyzer on (b)(6) 2016, resulting as 6.06 iu/ml (negative).The original sample was repeated again on the e411 analyzer on (b)(6) 2016, resulting as 4398 iu/ml accompanied by a data flag.The original sample was also repeated on an architect analyzer, resulting as 75.2 iu/ml (reactive) on (b)(6) 2016.The second sample was repeated again on the e411 analyzer on (b)(6) 2016, resulting as 5.57 iu/ml (negative).The second sample was also repeated on an architect analyzer, resulting as 5.4 iu/ml (grayzone) on (b)(6) 2016.The patient was not adversely affected.The serial number of the e411 analyzer was asked for, but not provided.
 
Manufacturer Narrative
A specific root cause could not be determined based on the provided information.Investigations have determined that there was no evidence of a malfunction of either the rubigg assay or with the analyzer.Based on the information provided, a sample mismatch is very likely.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5660352
MDR Text Key45322553
Report Number1823260-2016-00645
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
Reporter Country CodeVM
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/17/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2016
Device Catalogue Number04618793190
Device Lot Number189899
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received04/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-